Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Oxidation of drugs during drug product development : problems and solutions
ID
Gabrič, Alen
(
Author
),
ID
Hodnik, Žiga
(
Author
),
ID
Pajk, Stane
(
Author
)
PDF - Presentation file,
Download
(6,42 MB)
MD5: D229AF12DCF58E3F810422567FDE54AD
URL - Source URL, Visit
https://www.mdpi.com/1999-4923/14/2/325
Image galllery
Abstract
Oxidation is the second most common degradation pathway for pharmaceuticals, after hydrolysis. However, in contrast to hydrolysis, oxidation is mechanistically more complex and produces a wider range of degradation products; oxidation is thus harder to control. The propensity of a drug towards oxidation is established during forced degradation studies. However, a more realistic insight into degradation in the solid state can be achieved with accelerated studies of mixtures of drugs and excipients, as the excipients are the most common sources of impurities that have the potential to initiate oxidation of a solid drug product. Based on the results of these studies, critical parameters can be identified and appropriate measures can be taken to avoid the problems that oxidation poses to the quality of a drug product. This article reviews the most common types of oxidation mechanisms, possible sources of reactive oxygen species, and how to minimize the oxidation of a solid drug product based on a well-planned accelerated study.
Language:
English
Keywords:
oxidation
,
peroxides
,
impurities
,
new oxidative stressors
,
oxidative stress testing
Work type:
Article
Typology:
1.02 - Review Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
19 str.
Numbering:
Vol. 14, iss. 2, art. 325
PID:
20.500.12556/RUL-136994
UDC:
542.943:615
ISSN on article:
1999-4923
DOI:
10.3390/pharmaceutics14020325
COBISS.SI-ID:
100590851
Publication date in RUL:
27.05.2022
Views:
988
Downloads:
118
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Pharmaceutics
Shortened title:
Pharmaceutics
Publisher:
MDPI
ISSN:
1999-4923
COBISS.SI-ID:
517949977
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
01.02.2022
Secondary language
Language:
Slovenian
Keywords:
nečistoče
,
novi oksidativni stresorji
,
testiranje oksidativnega stresa
,
peroksidi
,
zdravila
,
oksidacija
,
oksidativni stres
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back